Kratom

For years, kratom has been clouded by controversy, largely fueled by media portrayals that paint a negative picture of this natural plant. Much of the confusion stems from a lack of distinction between kratom leaf and its more concentrated extracts, leading to a fragmented and inconsistent...

The Food and Drug Administration (FDA) has unexpectedly withdrawn its request for White House permission to conduct a study on the risks associated with kratom and psychedelics. As Marijuana Moment reported, this move comes in response to growing public criticism, particularly from advocates who...

Amid rising concerns over substance misuse among young people, North Carolina’s legislative bodies are intensifying efforts to regulate hemp-derived consumables with new legislation poised to reshape the state's cannabis market landscape. House Bill 563 Targets Hemp Product Access Last week,...

The Food and Drug Administration (FDA) has indicated a proactive stance toward establishing a regulatory framework for Cannabidiol (CBD) while continuing to monitor kratom closely. Kimberlee Trzeciak, FDA Deputy Commissioner for Policy, Legislation and International Affairs, announced the agency...

In the dynamic world of wellness, a new trend is gaining momentum: the embrace of kava, kratom and plant-based products. Leading the charge is Mitra9, co-founded by Dallas Vasquez who is introducing these traditional botanicals into the mainstream. Pioneering Wellness: The Mitra9 Mission A...

Following our previous roundup, numerous states are moving the discussion around psychedelics reform whether through decriminalization, legalization or rescheduling proposals or ancillary measures to access to the new therapies. A quick recap by November 3: California: TREAT, a citizen-led...

Cybin And Small Pharma Shareholders Green Light Acquisition Resolution Clinical-stage psychedelics biotechs Canada-based Cybin Inc. (NYSE: CYBN) and UK-based Small Pharma Inc. (OTCMKTS: DMTTF) held their respective annual general and special shareholders meetings on October 12. They announced that...

Congressional lawmakers from both sides of the aisle introduced a bicameral bill calling for further federal evaluation of kratom’s health and safety and prohibiting the Dept of Health and Human Services (HHS) from imposing more restrictive requirements on it than those for food or...

A family of a mother of four who died in 2021 after ingesting kratom is entitled to $11.6 million in damages. What Happened: Grow LLC, which is also known as KD Inc. and The Kratom Distro, and its owner, Sean Michael Harder, are obliged to pay the family of late Krystal Talavera $7 million in non-...

Congressman Blames FDA For Damaging Public Trust Due To Lack Of CBD Regs At a House Appropriations subcommittee hearing, a Republican congressman and staunch marijuana opponent accused the FDA of failing to regulate the CBD, causing "controversies" and "disrupting...

The Senate Judiciary Committee in West Virginia recently approved legislation that would place kratom, delta-8, and delta-10 products as Schedule 1 drugs. Kratom, a tropical plant native to Southeast Asia, is currently not illegal and can produce effects similar to opioids. Delta-8 THC and delta-10...

A bipartisan group of senators presented a bill to protect consumer access to kratom, a tropical plant native to Southeast Asia, which is currently not illegal and can produce effects similar to opioids, reported Marijuana Moment. Being legal, kratom is easily accessible around the U.S....

Kratom grows in several Asian countries and has been traditionally used by local communities as a natural home remedy for pain, depression and addiction. Now, several psychedelics companies are developing substances based on this plant and several US states have already enacted legislation that...

The Canadian-based psychedelics company Nirvana Life Sciences Inc. filed a patent for the deuterated form of 7-hydroxymitragynine (D7-h.), commonly known as Kratom. Nirvana focuses on developing mental health therapeutics including non-addictive chronic pain and relapse-...

The Federal Drug Administration is seeking public comments on kratom, a tropical plant native to Southeast Asia, which is currently not illegal and can have “opioid-like” effects. Due to its legality, kratom can be easily purchased around the country as a dietary supplement often used...